Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes

NCT01978405 is registered in ClinicalTrials.gov with Xiang Guang-da as lead sponsor.

NCT NCT01978405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01978405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
Lead sponsor
Xiang Guang-da
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2013
Completion date
June 30, 2014
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, the changes of endothelium-dependent arterial dilation, the changes of plasma creatinine, the changes of plasma free radicals